Intra-Operative Corticosteroid Injection During Arthroscopic Shoulder Surgery

• Status: Terminated
• Trial end date: 2020-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the efficacy of intra-operative subacromial corticosteroid injections in patients undergoing arthroscopic shoulder surgery on quality of life scores and activity level when compared to a control group.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Peter Chang
• Treatments: Bupivacaine; Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate

Criteria

Inclusion Criteria:

• Patients aged 18 years-old or older

• Male patients

• Female patients

• Patients able to speak and understand written English

• Patients presenting to the orthopedic institute clinic with shoulder pain and necessitating the procedure of arthroscopic shoulder surgery

• Specific arthroscopic procedures include: intra-articular debridement, decompression, acromioplasty, and acromioclavicular joint resection

Exclusion Criteria:

• Patients undergoing arthroscopic shoulder surgery that includes other interventions (i.e. rotator cuff repair; labral repair, etc)

• Patients with adhesive capsulitis

• Patients with significant cervical spine symptoms and/or pathology

• Patients having a history of receiving chronic pain treatment

• Patients who are currently pregnant or who become pregnant before surgery

• Patients who cannot speak or understand written english

• Patients who are under the age of 18 years of age

• As per exclusionary criteria if a subject is pregnant they will not be eligible for participation.